Bibliographies thématiques / Anti-amyloidogenic compounds

Sommaire

Articles de revues
Thèses
Chapitres de livres

Littérature scientifique sur le sujet « Anti-amyloidogenic compounds »

Auteur : Grafiati

Publié le 9 mars 2023

Mis à jour le 31 juillet 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Anti-amyloidogenic compounds ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Anti-amyloidogenic compounds"

Porzoor, Afsaneh, Benjamin Alford, Helmut Hügel, Danilla Grando, Joanne Caine, and Ian Macreadie. "Anti-Amyloidogenic Properties of Some Phenolic Compounds." Biomolecules 5, no. 2 (2015): 505–27. http://dx.doi.org/10.3390/biom5020505.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Hirohata, Mie, Kenjiro Ono, and Masahito Yamada. "Non-Steroidal Anti-Inflammatory Drugs as Anti-Amyloidogenic Compounds." Current Pharmaceutical Design 14, no. 30 (2008): 3280–94. http://dx.doi.org/10.2174/138161208786404173.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Skibiszewska and Jankowska. "Can Short Peptides Be Inhibitors of Serum Amyloid a Protein Aggregation?" Proceedings 22, no. 1 (2019): 38. http://dx.doi.org/10.3390/proceedings2019022038.

Texte intégral

Styles APA, Harvard, Vancouver, ISO, etc.

Tan, Mario A., Mark Wilson D. Lagamayo, Grecebio Jonathan D. Alejandro, and Seong Soo A. An. "Anti-Amyloidogenic and Cyclooxygenase Inhibitory Activity of Guettarda speciosa." Molecules 24, no. 22 (2019): 4112. http://dx.doi.org/10.3390/molecules24224112.

Texte intégral

Résumé :

Guettarda speciosa is known in traditional folk medicine for treating cough, cold, sore throat, fever, wounds, epilepsy, and headaches. To discover the scientific pharmacological potential of G. speciosa, we explore its anti-inflammatory, cytotoxicity, and inhibition of amyloid-beta (Aβ) aggregation effects. Cyclooxygenase assay of the G. speciosa CHCl3 (GSC) extract and G. speciosa MeOH (GSM) extract are more selective to COX-1 inhibition with a 50% inhibitory concentration (IC50) of 3.56 μg/mL for the GSC extract and 4.98 μg/mL for the GSM extract. Neuroblastoma SH-SY5Y inhibition and thiofl

Styles APA, Harvard, Vancouver, ISO, etc.

Yeo, Ji-Yun, Seul Lee, Min Sung Ko, et al. "Anti-Amyloidogenic Effects of Metasequoia glyptostroboides Fruits and Its Active Constituents." Molecules 28, no. 3 (2023): 1017. http://dx.doi.org/10.3390/molecules28031017.

Texte intégral

Résumé :

Alzheimer’s disease (AD) is a serious neurodegenerative brain disease that interferes with daily life. The accumulation of beta-amyloid (Aβ), along with oxidative stress-inducing neurocellular apoptosis, has been considered one of the causes of AD. Thus, the purpose of this study is to find natural products that can reduce Aβ accumulation. The ethanol extract of Metasequoia glyptostroboides Hu & Cheng fruits (Cupressaceae) significantly reduced the aggregation of Aβ into oligomers and fibrils determined by Thioflavin T (ThT) assay. The solvent-partitioned ethyl acetate layer was further se

Styles APA, Harvard, Vancouver, ISO, etc.

Jaipuria, Aadya, Madison Castillo, James Boksanski, et al. "Extended Chalcones: Synthesis, In Vitro Analysis, and In Vivo Testing Against a Drosophila melanogaster Alzheimer’s Disease Model." Chemistry 6, no. 6 (2024): 1477–94. http://dx.doi.org/10.3390/chemistry6060089.

Texte intégral

Résumé :

Alzheimer’s Disease (AD) is the most common form of dementia in individuals over the age of 65. There is no known prevention for the progression of the disease, although the FDA recently approved two drugs for AD. The exact etiology of AD is still under debate; however, it is commonly associated with the aggregation of amyloid-beta (Aβ) plaques in the brain. Recently some extended chalcones were reported to be potential anti-amyloidogenic agents. In this study, a larger library of extended chalcone analogs were synthesized with modifications on both rings. These were tested using the Thioflavi

Styles APA, Harvard, Vancouver, ISO, etc.

Quiroz, Jose Paredes, Andi Zeng, Michelle Young, et al. "Homotaurine and Curcumin Analogues as Potential Anti-Amyloidogenic Agents." Chemistry 5, no. 1 (2023): 223–41. http://dx.doi.org/10.3390/chemistry5010018.

Texte intégral

Résumé :

Currently, there is neither a cure for Alzheimer’s disease (AD) nor a way to stop the progressive death of neuronal cells associated with this devastating aliment. To date, there are only medications that temporarily slow its progression, and do not interfere with its pathogenesis. One of the hallmarks of AD is the presence of amyloid-beta plaques derived from the metabolism of the amyloid precursor protein, via the cleavage by beta followed by gamma secretase. Homotaurine, a naturally occurring small molecule found in some seaweeds, and curcumin, a phenolic antioxidant found in Curcuma longa,

Styles APA, Harvard, Vancouver, ISO, etc.

Marvastizadeh, Narges, Bahareh Dabirmanesh, Reza H. Sajedi та Khosro Khajeh. "Anti-amyloidogenic effect of artemin on α-synuclein". Biological Chemistry 401, № 10 (2020): 1143–51. http://dx.doi.org/10.1515/hsz-2019-0446.

Texte intégral

Résumé :

Abstractα-Synuclein fibrillation is now regarded as a major pathogenic process in Parkinson’s disease and its proteinaceous deposits are also detected in other neurological disorders including Alzheimer's disease. Therefore anti-amyloidegenic compounds may delay or prevent the progression of synucleinopathies disease. Molecular chaperones are group of proteins which mediate correct folding of proteins by preventing unsuitable interactions which may lead to aggregation. The objective of this study was to investigate the anti-amyloidogenic effect of molecular chaperone artemin on α-synuclein. As

Styles APA, Harvard, Vancouver, ISO, etc.

Ziaunys, Mantas, and Vytautas Smirnovas. "Exploring Epigallocatechin-3-Gallate Autoxidation Products: Specific Incubation Times Required for Emergence of Anti-Amyloid Properties." Antioxidants 11, no. 10 (2022): 1887. http://dx.doi.org/10.3390/antiox11101887.

Texte intégral

Résumé :

Amyloidogenic protein/peptide aggregation into fibrillar aggregates is associated with multiple amyloidoses, including widespread neurodegenerative disorders. Despite years of research and a well-understood mechanism, there are still very few treatments available for the increasing number of amyloid-related disorders. In recent years, the search for potential anti-aggregation compounds has shifted toward naturally occurring molecules, with one of the most promising being epigallocatechin-3-gallate (EGCG). This polyphenolic compound was shown to inhibit the aggregation of several amyloidogenic

Styles APA, Harvard, Vancouver, ISO, etc.

Lakey-Beitia, Johant, Jagadeesh Kumar D., Muralidhar Hegde, and K. S. Rao. "Carotenoids as Novel Therapeutic Molecules Against Neurodegenerative Disorders: Chemistry and Molecular Docking Analysis." International Journal of Molecular Sciences 20, no. 22 (2019): 5553. http://dx.doi.org/10.3390/ijms20225553.

Texte intégral

Résumé :

Alzheimer’s disease (AD) is the most devastating neurodegenerative disorder that affects the aging population worldwide. Endogenous and exogenous factors are involved in triggering this complex and multifactorial disease, whose hallmark is Amyloid-β (Aβ), formed by cleavage of amyloid precursor protein by β- and γ-secretase. While there is no definitive cure for AD to date, many neuroprotective natural products, such as polyphenol and carotenoid compounds, have shown promising preventive activity, as well as helping in slowing down disease progression. In this article, we focus on the chemistr

Styles APA, Harvard, Vancouver, ISO, etc.

Plus de sources

Thèses sur le sujet "Anti-amyloidogenic compounds"

SIRONI, ERIKA. "Nuclear Magnetic Resonance characterization of Beta-amyloid peptides and their interactions with anti-amyloidogenic compounds." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2013. http://hdl.handle.net/10281/41573.

Texte intégral

Résumé :

Neurotoxic aggregates generated by amyloid beta peptides (Abeta) represent one of the main pathological features of Alzheimer’s Disease (AD). Nowadays many natural and synthetic compounds able to prevent Abeta peptide toxicity and aggregation have already been identified. Several of these compounds are not soluble in water, are chemically unstable and/or show pharmacological activities not directly correlated to AD. Among these, tetracycline, rosmarinic acid and curcumin, were analyzed for their ability to bind Abeta peptides. For this purpose NMR spectroscopy has been mainly employed, with th

Styles APA, Harvard, Vancouver, ISO, etc.

Chapitres de livres sur le sujet "Anti-amyloidogenic compounds"

"Rational design, synthesis and biological evaluation of dual- binding reversible inhibitors of cholinesterase’s with mild inhibitory potency toward monoamine oxidase B." In Book of Abstracts - RAD 2025 Conference. RAD Centre, Niš, Serbia, 2025. https://doi.org/10.21175/rad.abstr.book.2025.21.3.

Texte intégral

Résumé :

Alzheimer’s disease (AD) is neurodegenerative disease that is the cause of 60-70% of dementia cases. The major symptoms of AD involve progressive decline of cognitive and motor skills, caused by neuropathological changes, including elevation of oxidative stress, shrinkage of neurons, formation of Aβ plaques and neurofibrillary tangles in the central nervous system (CNS) and disruption of glutamatergic and cholinergic neurotransmission systems. In AD, the nerve terminal disruption is observed in immediate vicinity of Aβ plaques. Peripheral ionic site of AChE promotes aggregation of Aβ peptides

Styles APA, Harvard, Vancouver, ISO, etc.

Pattnaik, Prachi, Chetan Panda, Tarun Minocha, Sanjeev Kumar Yadav, Namrata Dwivedi, and Sandeep Kumar Singh. "Bacopa monnieri and Neural Health: An Indian Herb." In Traditional Medicine for Neuronal Health. BENTHAM SCIENCE PUBLISHERS, 2023. http://dx.doi.org/10.2174/9789815040197123010011.

Texte intégral

Résumé :

The disorders of the central nervous system are increasingly recognized as one of the most prevalent disorders in the present world. It has been envisaged that neurological disorders will be of great concern in the present and future populations worldwide. The different neurological disorders may be associated with signs, such as loss of memory, impaired brain function, cognitive deficits, etc. The occurrence of such degenerative diseases of the nervous system certainly imposes medical and public health burdens on populations worldwide. The multifactorial nature of such neural disorders entail

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!